Mepolizumab and the response to oral prednisolone in patients with severe eosinophilic asthma

Detalles Bibliográficos
Autores principales:	Shrimanker, R, Hargaden, B, Bradding, P, Wardlaw, A, Brightling, C, Green, R, Bafadhel, M, Heaney, L, Pavord, I, Haldar, P
Formato:	Conference item
Publicado:	European Respiratory Society 2017

Ejemplares similares